Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CENPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRIM2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBCE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR8G2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGF1R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM98B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC81691 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPB41L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDH1B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARNTL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AURKA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MLF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCPH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GJB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSE1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZAK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on